Case report: Angiosarcoma after lung transplant (2013)

Record number: 
920
Adverse Occurrence type: 
MPHO Type: 
Estimated frequency: 
Most recent risk assessment for sarcoma (Council of Europe, 2022): Due to the very aggressive behavior of sarcoma, they are considered an unacceptable risk for organ donation at any stage of disease. Sarcoma in donor history: Because of the very aggressive behavior of sarcoma, they are mostly considered an unacceptable risk for organ donation. After curative treatment and a recurrence-free survival of > 5 years, sarcomas are still assumed to be associated with a high risk for transmission.
Time to detection: 
4 months
Alerting signals, symptoms, evidence of occurrence: 
Not specified
Demonstration of imputability or root cause: 
Several recipients affected: two kidneys, liver and lung recipients (heart recipient disease-free in the report). No more details provided.
Suggest references: 
aaa